Tollovid™ + Long COVID:
Exploring Viral Persistence
in PASC as a Target

Case Studies, Observational,
and Retrospective Studies

August 2022 Report

We are excited to learn how Tollovid is positively impacting those suffering from lingering PASC symptoms.

Long COVID is impacting millions of people. If you have long-term effects related to COVID, you’re not alone. Tollovid™ is committed to finding answers. Our research team is working to learn more about the long-term effects of COVID so we can help.

Ongoing Market Research Study
We are compiling 35+ individual case studies with PASC participants as their physicians monitor their symptoms and progress on Tollovid™ over 30, 60, and 90 day periods.

Upcoming Clinical Synopsis
We are also conducting a randomized, observer blinded, non-exposure control study to evaluate the safety of TollovidTM and Tollovid’s effects on the structure/function of the immune system in subjects with Long COVID. We’re currently developing study protocol to evaluate the safety and structure/function effects of Tollovid.

What is Long COVID?

Building Our Understanding of COVID Recovery

Long COVID, or post-acute sequelae of COVID-19 (PASC), is a condition marked by the continuation of COVID-19 symptoms—or the emergence of new ones—after recovery from acute COVID-19. It generally refers to the persistence of symptoms four weeks or longer after the onset of COVID-19.

About PASC Symptoms:
Long-term effects of COVID can be different for everyone and they can affect many different parts of the body, such as the heart, brain, and lungs. And people who have PASC, including Long COVID, can have different kinds of effects. These effects may come and go, and they may last for a few weeks, a few months, or longer.

PASC Symptoms Include:

  • Shortness of Breath
  • Cough
  • Fatigue
  • Rash
  • Gastrointestinal Symptoms
  • Insomnia
  • Tachycardia
  • Dizziness
  • Headaches
  • Orthostatic Intolerance
  • Menstrual Cycle Changes
  • Libido / Sexual Function
  • Tinnitus
  • Brain Fog
  • Memory Loss
  • Joint Pain

Observational Study Data: Key Highlights

Case Study Data: April - August 20, 2022 n = 104

Please note that our market studies are still ongoing. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure,or prevent any disease.

94%

of Acute COVID-19 respondents reported a decrease in Acute COVID Symptoms.

90%

of Long COVID (0-6 months) respondents reported a decrease in Long COVID Symptoms.

81%

of Long COVID (0-9 months) respondents reported a decrease in Long COVID Symptoms.

95%

of Acute COVID-19 respondents reported that they were happy with their results with Tollovid.

80%

of Long COVID (0-6 months) respondents reported that they were happy with their results.

67%

of Long COVID (0-9 months) respondents reported that they were happy with their results.

Download the Full Report

Ongoing Marketing Case Studies: Key Highlights

CASE STUDY #1

“All of her symptoms were eliminated within 1 week. At the end of the week she also tested negative by PCR.”

Female

49 years old

3 months

months with PASC symptoms.

7 days

until symptom relief.

4 months

duration of effect.

ENDPOINT HIGHLIGHTS:

  1. Negative PCR after 1 week
  2. Back to Work after absence of 3 months
  3. No Return of Symptoms after 4 months
Read the Full Report

SYMPTOMS INCLUDE:

  • Fatigue
  • Insomnia
  • Headaches
  • Joint Pain

CASE STUDY #2

“After 3 days, his fatigue and joint pain subsided, his memory improved, and his erectile dysfunction resolved.”

Male

33 yearsold

24 months

months with PASC symptoms.

3 days

until symptom relief.

3 months

duration of effect.

ENDPOINT HIGHLIGHTS:

  1. Able to Walk the Dog, 2x daily
  2. Back to Working Out, 5x weekly
  3. No Longer Treating for PASC Symptoms
Read the Full Report

SYMPTOMS INCLUDE:

  • Fatigue
  • Insomnia
  • Dizziness
  • Joint Pain
  • Brain Fog
  • Sexual Dysfunction

CASE STUDY #3

“As of three days ago, all her symptoms were resolved. She attributes this recovery to the treatment with Tollovid."

Female

53 years old

5 months

months with PASC symptoms.

1 day

until symptom relief.

Rebounder

of Paxlovid.

ENDPOINT HIGHLIGHTS:

  1. Negative PCR after 2 weeks
  2. Back to Regular Hikes & Walks, 5 miles
  3. Continuing to take 2 capsules, 2x daily
Read the Full Report

SYMPTOMS INCLUDE:

  • Fatigue
  • Tinnitus
  • Insomnia
  • Brain Fog
  • Fever
  • Joint Pain
  • Gastrointestinal Issues
  • Shortness of Breath
  • Changes in Libido

CASE STUDY #4

“After taking Tollovid, my flare-ups are less intense with a rating of only 3 out of 10. Because of Tollovid, I am suffering less now.”

Male

33 years old

14 months

months with PASC symptoms.

4 days

until symptom relief.

3+ weeks

duration of effect.

ENDPOINT HIGHLIGHTS:

  1. Decreased Blood Pressure & Heart Rate
  2. Increased Energy Level
  3. Less Intense Symptoms Flareups
Read the Full Report

SYMPTOMS INCLUDE:

  • Fatigue
  • Insomnia
  • Heart Palpitations
  • Gastrointestinal Issues
  • Brain Fog
  • Vision Issues

CASE STUDY #5

“Tollovid has gotten me back to 85% of my pre-COVID state. No other intervention I’ve tried so far has been able to do that.”

Male

36 years old

5 months

months with PASC symptoms.

2 days

until symptom relief.

3+ weeks

duration of effect.

ENDPOINT HIGHLIGHTS:

  1. Erectile Dysfunction Resolved
  2. Reduced Anxiety and Improved GI Function
  3. Less Frequent Pins and Needles
Read the Full Case Study

SYMPTOMS INCLUDE:

  • Fatigue
  • Joint Pain
  • Pins & Needles
  • Headaches
  • Anxiety
  • Insomnia
  • Gastrointestinal Issues
  • Urinary Issues
  • Sexual Dysfunction

CASE STUDY #6

“After 5 days of Tollovid, I have recovered to 85%. I can run for 30 minutes, and my resting heart rate is back down to 60 bpm.”

Male

46 years old

7 months

months with PASC symptoms.

5 days

until symptom relief.

4+ weeks

duration of effect.

ENDPOINT HIGHLIGHTS:

  1. Sleep Improved & Dizziness Abated
  2. Back to Running, 30 minutes daily
  3. Decreased Resting Heart Rate, 60 bpm
Read the Full Report

SYMPTOMS INCLUDE:

  • Fatigue
  • Anxiety
  • Breathing
  • Headache
  • Insomnia
  • Heart Palpitations

How You Can Help?

We’re looking for people to volunteer for research studies on the long-term effects of COVID.
You can sign up for more information at:

Join Our Long COVID Immunity Community
Participate in Our Ongoing PASC Research Studies

Stay informed of our latest breakthroughs.